COPA综合征:欧洲38例多中心队列的新发现
该研究评估了46名携带COPA突变的个体(29个家系),其中38例出现至少1种与突变相关的临床表现,临床外显率为83%。除确认肺、关节和肾脏核心受累外,还发现心脏、皮肤和胃肠道等新表现,提示与SAVI等I型干扰素病存在临床重叠。
要点
- COPA综合征临床外显率83%,中位发病年龄3岁,肺部受累最常见。
- 新发现心脏、皮肤、胃肠道和肝脏受累,扩展了疾病表型谱。
核心结论
- COPA综合征除肺、关节、肾脏核心表现外,还可累及心脏、皮肤、胃肠道和肝脏,与SAVI等I型干扰素病临床重叠。
研究设计与样本
- 研究纳入29个家系共46名携带COPA突变的个体,评估临床、影像和免疫学数据。
主要发现
- 46名携带者中38例出现至少1种与突变相关的临床表现,临床外显率为83%。
- 34例患者有肺部受累,其中31例为间质性肺病,11例为弥漫性肺泡出血。
临床怎么用
- 对疑似COPA综合征患者应评估肺、关节、肾脏外的心脏、皮肤和胃肠道受累。
- JAK抑制剂可作为COPA综合征的治疗选择之一,但需更多证据确认。
局限性
- 本研究为多中心队列描述性分析,未设对照组,JAK抑制剂疗效需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: COPA (coatomer subunit alpha) syndrome is a rare monogenic autoinflammatory disease due to heterozygous mutations in COPA. It has phenotypic overlap with STING (Stimulator of interferon genes)-associated vasculopathy with onset in infancy (SAVI), although the spectrum of clinical manifestations is not yet fully defined. Our aim was to better delineate the clinical phenotype of this rare disorder in a European cohort. METHODS: Methods include assessment of clinical, imaging, and immunological data from 46 individuals (29 families) carrying a COPA mutation. RESULTS: Among the 46 individuals carrying a COPA mutation, 38 had at least 1 clinical manifestation likely related to their mutant state (clinical penetrance of 83%). Twenty-two (58%) symptomatic patients were female, with a median age at disease onset of 3 years (range 0-50 years). Pulmonary involvement was observed in 34 patients, with interstitial lung disease in most cases (n = 31) and diffuse alveolar haemorrhage in 11 individuals. Twenty-six patients demonstrated joint involvement, and 7 had documented kidney disease. Previously undescribed features included skin (n = 12), cardiac (n = 8), gastrointestinal (n = 7), and hepatic involvement (n = 5). All but 1 patient tested positive for autoantibodies, and increased interferon signalling was noted in all those tested. Twenty-two patients were treated with Janus kinase inhibitors with promising efficacy. CONCLUSIONS: We report a large European cohort of patients with COPA syndrome. While confirming the core organ features (lung, joint, and kidney) of the disease, our data expand the phenotype to include cardiac, skin, and gastrointestinal features, further demonstrating the clinical overlap with SAVI and other type I interferonopathies.
引用
- David C, Nathan N, Al-Abadi E, et al. Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome. Ann Rheum Dis. 2025. PMID: 41395910. doi:10.1016/j.ard.2025.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。